Showing results (181-190 of 781) with videos related to

Sort By:
Pageof 79
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Best treatment strategies in high-risk multiple myeloma: navigating a gray areaGiada Bianchi, Paul G Richardson, Kenneth C Anderson
Expert Opinion on Investigational Drugs|January 26, 2006
Current therapeutic uses of lenalidomide in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C Anderson
Molecular Cancer Therapeutics|November 11, 2011
Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myelomaTeru Hideshima, Paul G Richardson, Kenneth C Anderson
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancersPaul G Richardson, Teru Hideshima, Kenneth C Anderson
Reviews in Clinical and Experimental Hematology|February 7, 2004
Targeting proteasome inhibition in hematologic malignanciesTeru Hideshima, Paul G Richardson, Kenneth C Anderson
Hematology/Oncology Clinics of North America|September 13, 2014
Immunotherapy strategies in multiple myelomaJooeun Bae, Nikhil C Munshi, Kenneth C Anderson
Brain Research. Developmental Brain Research|April 12, 2002
Regional specification of rodent and human neurospheresT Ostenfeld, Etienne Joly, Yu Tzu Tai, et al.
Pageof 79